Financial reports
10-Q
2024 Q1
Quarterly report
26 Apr 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
10-K
2023 FY
Annual report
26 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
28 Apr 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
28 Oct 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
Current reports
8-K
BioMarin Reports Record Financial Results for the First Quarter 2024
24 Apr 24
8-K
Other Events
23 Apr 24
8-K
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
22 Feb 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
BioMarin Announces Governance Enhancements and Value Creation Initiatives
20 Dec 23
8-K
Departure of Directors or Certain Officers
3 Nov 23
8-K
BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year
1 Nov 23
8-K
Results of Operations and Financial Condition
31 Jul 23
8-K
Departure of Directors or Certain Officers
30 May 23
8-K
BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
26 Apr 23
Registration and prospectus
S-8
Registration of securities for employees
2 Nov 23
S-8
Registration of securities for employees
17 Feb 22
S-8
Registration of securities for employees
16 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 18
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Aug 18
424B5
Prospectus supplement for primary offering
9 Aug 17
FWP
Free writing prospectus
9 Aug 17
424B5
Prospectus supplement for primary offering
8 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jun 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jun 17
Proxies
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Apr 22
DEF 14A
Definitive proxy
12 Apr 22
DEFA14A
Additional proxy soliciting materials
17 May 21
DEFA14A
Additional proxy soliciting materials
13 Apr 21
DEF 14A
Definitive proxy
13 Apr 21
DEFA14A
Additional proxy soliciting materials
14 Apr 20
Other
UPLOAD
Letter from SEC
10 Apr 23
CORRESP
Correspondence with SEC
6 Apr 23
UPLOAD
Letter from SEC
30 Mar 23
UPLOAD
Letter from SEC
29 Mar 22
CORRESP
Correspondence with SEC
23 Feb 22
UPLOAD
Letter from SEC
31 Jan 22
CORRESP
Correspondence with SEC
20 Dec 21
UPLOAD
Letter from SEC
7 Dec 21
CT ORDER
Confidential treatment order
12 Feb 18
CT ORDER
Confidential treatment order
17 Nov 17
Ownership
4
JEAN JACQUES BIENAIME
15 Apr 24
4
Erin Burkhart
12 Apr 24
144
Notice of proposed sale of securities
12 Apr 24
144
Notice of proposed sale of securities
11 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
4
George Eric Davis
1 Apr 24
144
Notice of proposed sale of securities
28 Mar 24
4
Dennis Slamon
20 Mar 24
4
Erin Burkhart
19 Mar 24
4
George Eric Davis
19 Mar 24